MYO1G anticorps (AA 209-389) (HRP)

N° du produit ABIN7174952

Détail du produit anti-MYO1G anticorps (HRP)

Antigène: MYO1G (Myosin IG (MYO1G))

Épitope: AA 209-389

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MYO1G est conjugé à/à la HRP

Application: ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Unconventional myosin-Ig protein (209-389AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur MYO1G

Antigène: MYO1G (Myosin IG (MYO1G))

Autre désignation: MYO1G (MYO1G Produits)

Synonymes: anticorps HA2, anticorps MHAG, anticorps E430002D17Rik, anticorps myosin IG, anticorps MYO1G, anticorps Myo1g

Sujet:

Background: Unconventional myosin required during immune response for detection of rare antigen-presenting cells by regulating T-cell migration. Unconventional myosins are actin-based motor molecules with ATPase activity and serve in intracellular movements. Acts as a regulator of T-cell migration by generating membrane tension, enforcing cell-intrinsic meandering search, thereby enhancing detection of rare antigens during lymph-node surveillance, enabling pathogen eradication. Also required in B-cells, where it regulates different membrane/cytoskeleton-dependent processes. Involved in Fc-gamma receptor (Fc-gamma-R) phagocytosis.

Aliases: mHag HA-2 antibody, Minor histocompatibility antigen HA-2 antibody, Myo1g antibody, MYO1G_HUMAN antibody, myosin IG antibody

UniProt: B0I1T2